PhD candidate
We study the use of ultrasound contrast agents, i.e. microbubbles of 1-10 µm in size, for local drug delivery and ultrasound molecular imaging.
At the crossroads of physics, technology, biology and medicine, we develop technology for insights in cardiovascular disease, and to improve its diagnosis and treatment.
Drug delivery through microbubbles: the quest for the missing link (VIDI Kooiman)
